Literature DB >> 15123071

Microbial-gut interactions in health and disease. Probiotics.

Erika Isolauri1, Seppo Salminen, Arthur C Ouwehand.   

Abstract

The definition of probiotics has evolved from a live active culture which improves the balance of the gut microbiota composition to specific effects, in particular, the immunomodulatory potential of clearly defined strains. The strains with beneficial properties, potential sources of probiotics, most frequently belong to the genera Bifidobacterium and Lactobacillus, and some of these strains exhibit powerful anti-inflammatory properties. Indeed, probiotic therapy has attracted research interest in human infectious, inflammatory and allergic disease. The most fully documented disease altering the gut microbiota is acute infectious diarrhoea in childhood. Current probiotic research aims to provide safe but sufficient bacterial stimulus in order to avert deviant immune responsiveness related to allergic and inflammatory diseases. However, further rigorous scientific efforts are required to characterize the immunomodulatory potential of specific probiotic strains for these targets.

Entities:  

Mesh:

Year:  2004        PMID: 15123071     DOI: 10.1016/j.bpg.2003.10.006

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  51 in total

1.  A quantitative study of the morphological development and bacterial colonisation of the gut of the tammar wallaby Macropus eugenii eugenii and brushtail possum Trichosurus vulpecula during in-pouch development.

Authors:  R G Lentle; D Dey; C Hulls; D J Mellor; P J Moughan; K J Stafford; K Nicholas
Journal:  J Comp Physiol B       Date:  2006-07-04       Impact factor: 2.200

2.  Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: involvement of toll-like receptors.

Authors:  Gabriel Vinderola; Chantal Matar; Gabriela Perdigon
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

Review 3.  Probiotics in the management of colonic disorders.

Authors:  Eamonn M M Quigley
Journal:  Curr Gastroenterol Rep       Date:  2007-10

Review 4.  Probiotic supplementation in children with cystic fibrosis-a systematic review.

Authors:  Anitha Ananthan; Haribalakrishna Balasubramanian; Shripada Rao; Sanjay Patole
Journal:  Eur J Pediatr       Date:  2016-08-30       Impact factor: 3.183

5.  Proteomic analysis of global changes in protein expression during bile salt exposure of Bifidobacterium longum NCIMB 8809.

Authors:  Borja Sánchez; Marie-Christine Champomier-Vergès; Patricia Anglade; Fabienne Baraige; Clara G de Los Reyes-Gavilán; Abelardo Margolles; Monique Zagorec
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

Review 6.  The Current Status of the Alternative Use to Antibiotics in Poultry Production: An African Perspective.

Authors:  Letlhogonolo Andrew Selaledi; Zahra Mohammed Hassan; Tlou Grace Manyelo; Monnye Mabelebele
Journal:  Antibiotics (Basel)       Date:  2020-09-11

7.  Ability of probiotic Lactobacillus casei DN 114001 to bind or/and metabolise heterocyclic aromatic amines in vitro.

Authors:  Adriana Nowak; Zdzislawa Libudzisz
Journal:  Eur J Nutr       Date:  2009-05-16       Impact factor: 5.614

8.  Integrated transcriptomic and proteomic analysis of the bile stress response in a centenarian-originated probiotic Bifidobacterium longum BBMN68.

Authors:  Haoran An; François P Douillard; Guohong Wang; Zhengyuan Zhai; Jin Yang; Shuhui Song; Jianyun Cui; Fazheng Ren; Yunbo Luo; Bing Zhang; Yanling Hao
Journal:  Mol Cell Proteomics       Date:  2014-06-25       Impact factor: 5.911

Review 9.  What is the evidence for the use of probiotics in functional disorders?

Authors:  Eamonn M M Quigley
Journal:  Curr Gastroenterol Rep       Date:  2008-08

10.  Application of sequence-dependent electrophoresis fingerprinting in exploring biodiversity and population dynamics of human intestinal microbiota: what can be revealed?

Authors:  Geert Huys; Tom Vanhoutte; Peter Vandamme
Journal:  Interdiscip Perspect Infect Dis       Date:  2008-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.